| Literature DB >> 35756122 |
Md Mukthar Mia1,2, Mahamudul Hasan2, M Rashed Hasnath1.
Abstract
Pigeons have been considered the most preferred companion for human civilizations since prehistoric times. Despite the fact that pigeons offer the most palatable and nutritious food and provide pleasure to humans, they can pose a health risk because of carrying infectious and zoonotic organisms. Moreover, the scanty of systematic reports on the occurrence of zoonotic pathogens in pigeon makes the situations worst. Hence, the current study conducted a systematic review and meta-analysis to evaluate the global prevalence of zoonotic pathogens among the pigeon population from existing segregated literatures. Four internationally recognized databases including Google Scholar, Scopus, PubMed, and Science Direct were used to search the published studies from January 2000 to October 2021. Analyzing the total 18,589 samples, mean prevalence estimates of pigeon pathogens worldwide were found to be 17% (95% CI:13-21) whereas serological and molecular prevalence were reported as 18% (95% CI:12-23) and 17% (95% CI:10-23). Meanwhile, virus, bacteria, and protozoal pathogens were found to be 21% (10-32%), 17% (12-23%), and 14% (10-19%), respectively. Moreover, continent wise analysis of all zoonotic pigeon pathogens has revealed the highest prevalence rate in Asia 20% (95% CI: 14-26%), followed by Europe 16% (95% CI: 08-24%), Africa 16% (95% CI: 07-24%), and America (North and South) 10% (95% CI: 03-17%). Furthermore, the highest number of studies were reported from Iran showed the prevalence rate of 20%, China 13%, Bangladesh 37%, and Poland 15%. Therefore, this prevalence of data would be helpful to the policymakers to develop appropriate intervention strategies to prevent and control diseases in their respective locations.Entities:
Keywords: Diagnostic test; Meta-analysis; Pigeon; Prevalence; Zoonotic pathogens
Year: 2022 PMID: 35756122 PMCID: PMC9218837 DOI: 10.1016/j.heliyon.2022.e09732
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Flow chart describing the procedures of choosing eligible studies.
Characteristics of the included studies.
| Authors name and year | Representativeness of the sample | Diagnostic method |
|---|---|---|
| ( | Cloacal and pharyngeal swabs | TaqMan Real-Time PCR Screening |
| ( | Blood samples | Conventional PCR |
| ( | Faecal samples | Nested PCR |
| ( | Cloacal swabs, pharyngeal swabs | PCR |
| ( | Fecal sample | Nested PCR |
| ( | Cloacal swab samples, | PCR |
| ( | Pharyngeal and cloacal samples | Nested PCR |
| ( | Pharyngeal swabs | Nested PCR |
| ( | Cloacal swab | PCR |
| ( | Blood and tissue samples | ELISA |
| ( | Blood serum samples | Latex agglutination test (LAT) |
| ( | Muscle biopsies | DNA by semi-nested PCR |
| ( | Blood samples | PCR |
| ( | Intestine, spleen and liver | PCR |
| ( | Blood samples | Blocking ELISA |
| ( | Blood samples | Indirect hemagglutination assay |
| ( | Droppings | Nested PCR |
| ( | Feces | PCR |
| ( | Pharyngeal swabs | PCR |
| ( | Samples from intestine | PCR |
| ( | Blood samples | Indirect Haemagglutination assay |
| ( | Cloaca, crop and faeces of birds | PCR |
| ( | Cloacal swabs | PCR |
| ( | Pharyngeal swab | Nested PCR |
| ( | Choanal-cloacal swabs, liver samples | Real-time PCR |
| ( | Blood sample | Haemagglutination inhibition test |
| ( | Cloacal sample | Multiplex PCR |
| ( | Cloacal swab | PCR |
| ( | Blood sample | Modified Agglutination Test |
| ( | Dead or alive, healthy pigeons | Nested PCR |
| ( | Blood sample | Modified agglutination test |
| ( | Blood sample | Hemagglutination Inhibition |
| ( | Blood, organs and intestine contents | Commercial Elisa kit |
| ( | Cloacal and tracheal swabs | Hemi-nested PCR |
| ( | Spleen samples | PCR |
| ( | Fresh feces samples | Multiplex PCR |
| ( | Cloacal swabs | PCR |
| ( | Pigeon eggs | PCR |
| ( | Oral and cloacal; swabs | PCR |
| ( | Blood samples | Modified agglutination test |
| ( | Blood samples | Neospora Agglutination test (NAT) and PCR |
| ( | Cloacal swab samples | RT-PCR |
| ( | Faecal samples | PCR |
| ( | Blood samples | Haemagglutination inhibition test |
| ( | Blood samples | Haemagglutination inhibition test |
| ( | Swab and feces sample | Conserved RT-PCR assay |
| ( | Cloacal swabs | Haemagglutination inhibition |
| ( | Oropharynx and cloaca | Nested RT-PCR |
| ( | Blood sample | Haemagglutination inhibition |
Continent wise zoonotic diseases’ prevalence from pigeon bird.
| Region/Continent with total prevalence | Country | Infection/Disease(s) |
|---|---|---|
| Asia (20%) | Iraq, Bangladesh, Iran, Taiwan, China, Thailand, Israel, Japan, Taiwan | |
| Europe (16%) | Poland, Switzerland, Belgium, Italy, Germany, Spain, Czech Republic, Hungary, Norway, Croatia, Slovak Republic | |
| Africa (16%) | Egypt, Nigeria | Toxoplasma gondii, Newcastle disease virus (NDV) |
| North and South America (10% (95% CI: 03–17) | Costa Rica, Chile, Brazil |
Figure 2Visualizing forest plot described pooled prevalence of zoonotic diseases from pigeon.
Figure 3Graphically representation of funnel plot described studies heterogenicity.
Figure 4Forest plot for representation of continent wise prevalence; A) Asia; B) Europe; C) North and South America; and D) Africa
Figure 5Graphical representation of continent wise prevalence in world map.
Figure 6PCR based pooled prevalence.
Prevalence of zoonotic diseases from pigeon based on different diagnostic tests.
| Diagnostic test | Random effect model | Fixed model | ||||
|---|---|---|---|---|---|---|
| No. of Studies | Prevalence (%) (95% CI) | I2 (%) | H2 | Tau2 | Prevalence (%) (95% CI) | |
| PCR (Molecular) | 34 | 18 (12–23) | 99.18 | 122.4 | 0.022 | 06 (06–07) |
| ELISA/Agglutination test/Haemagglutination assay/Haemagglutination inhibition (Serological) | 15 | 17 (10–23) | 98.66 | 74.6 | 0.014 | 17 (16–17) |
Figure 7Forest plot for representation of country wise prevalence; A) Iran; B) China; C) Bangladesh; and D) Poland.
Country wise disease prevalence with causal agent.
| Country | Type of causal agent | Random effect model | ||||
|---|---|---|---|---|---|---|
| No. of Studies | Prevalence (%) (95% CI) | I2 (%) | H2 | Tau2 | ||
| Iran | 09 | 20 (09–30) | 99.11 | 111.9 | 0.024 | |
| Chin | 05 | 13 (04–22) | 98.56 | 69.2 | 0.010 | |
| Bangladesh | 04 | 37 (26–48) | 69.81 | 3.3 | 0.008 | |
| Poland | 03 | 15 (-02–31) | 98.54 | 68.2 | 0.020 | |
Figure 8Forest plot showing the pooled prevalence rate based on causal agent; A) Salmonella spp.; B) Escherichia coli.
Figure 9Forest plot showing the pooled prevalence of diseases; A) Bacterial; B) Viral; and C) Protozoal.
Prevalence viral, bacterial, and protozoal zoonotic disease from pigeon.
| Type of causal agent | Random effect model | Fixed model | ||||
|---|---|---|---|---|---|---|
| No. of Studies | Prevalence (%) (95% CI) | I2 (%) | H2 | Tau2 | Prevalence (%) (95% CI) | |
| Virus | 10 | 21 (10–32) | 99.35 | 153.17 | 0.030 | 17 (16–17) |
| Bacteria | 26 | 17 (12–23) | 99.22 | 128.92 | 0.022 | 06 (05–06) |
| Protozoa | 13 | 14 (10–19) | 96.50 | 28.53 | 0.006 | 10 (09–11) |
Figure 10Forest plot showing the pooled prevalence rate based on causal agent; A) Chlamydia psittaci; B) Toxoplasma gondii; C) Campylobacter spp., and D) Newcastle Disease Virus.
Prevalence of zoonotic diseases categorized by causal agent.
| Type of causal agent | Random effect model | Fixed model | ||||
|---|---|---|---|---|---|---|
| No. of Studies | Prevalence (%) (95% CI) | I2 (%) | H2 | Tau2 | Prevalence (%) (95% CI) | |
| 04 | 24 (04–44) | 98.79 | 82.89 | 0.040 | 35 (33–36) | |
| 10 | 17 (09–26) | 98.76 | 80.37 | 0.018 | 05 (05–06) | |
| 04 | 18 (-09–44) | 99.77 | 428.91 | 0.069 | 02 (01–02) | |
| Newcastle Disease | 04 | 27 (11–42) | 99.20 | 124.86 | 0.023 | 33 (32–34) |
| 05 | 17 (06–28) | 95.98 | 24.88 | 0.014 | 07 (06–09) | |
| 07 | 09 (06–12) | 91.47 | 11.72 | 0.001 | 07 (06–08) | |